Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, OH.
The Ohio State University College of Medicine, Columbus, OH.
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2727-2737. doi: 10.1053/j.jvca.2021.09.051. Epub 2021 Oct 3.
Post-acute coronavirus disease 2019 (COVID-19) syndrome is a novel, poorly understood clinical entity with life-impacting ramifications. Patients with this syndrome, also known as "COVID-19 long-haulers," often present with nonspecific ailments involving more than one body system. The most common complaints include dyspnea, fatigue, brain fog, and chest pain. There currently is no single agreed-upon definition for post-acute COVID-19 syndrome, but most agree that criterion for this syndrome is the persistence of mental and physical health consequences after initial infection. Given the millions of acute infections in the United States over the course of the pandemic, perioperative providers will encounter these patients in clinical practice in growing numbers. Symptoms of the COVID-19 long-haulers should not be minimized, as these patients are at higher risk for postoperative respiratory complications and perioperative mortality for up to seven weeks after initial illness. Instead, a cautious multidisciplinary preoperative evaluation should be performed. Perioperative care should be viewed through the prism of best practices already in use, such as avoidance of benzodiazepines in patients with cognitive impairment and use of lung-protective ventilation. Recommendations especially relevant to the COVID-19 long-haulers include assessment of critical care myopathies and neuropathies to determine suitable neuromuscular blocking agents and reversal, preoperative workup of insidious cardiac or pulmonary pathologies in previously healthy patients, and, thorough medication review, particularly of anticoagulation regimens and chronic steroid use. In this article, the authors define the syndrome, synthesize the available scientific evidence, and make pragmatic suggestions regarding the perioperative clinical care of COVID-19 long-haulers.
新型冠状病毒病 2019(COVID-19)后综合征是一种新的、尚未被充分了解的临床实体,具有影响生活的后果。患有这种综合征的患者,也称为“COVID-19 长期患者”,常表现为涉及多个身体系统的非特异性疾病。最常见的抱怨包括呼吸困难、疲劳、脑雾和胸痛。目前对于 COVID-19 后综合征没有单一的共识定义,但大多数人同意该综合征的标准是在初始感染后,精神和身体健康后果的持续存在。考虑到美国在大流行期间发生了数百万例急性感染,围手术期提供者在临床实践中会遇到越来越多的这些患者。COVID-19 长期患者的症状不应被低估,因为这些患者在初始疾病后长达七周内发生术后呼吸并发症和围手术期死亡的风险更高。相反,应进行谨慎的多学科术前评估。应通过已经在使用的最佳实践来看待围手术期护理,例如避免在认知障碍患者中使用苯二氮䓬类药物以及使用肺保护性通气。与 COVID-19 长期患者特别相关的建议包括评估重症监护相关肌病和神经病,以确定合适的神经肌肉阻滞剂和逆转剂,对先前健康的患者进行隐匿性心脏或肺部疾病的术前检查,以及彻底审查药物,特别是抗凝方案和慢性类固醇的使用。在本文中,作者定义了该综合征,综合了现有的科学证据,并就 COVID-19 长期患者的围手术期临床护理提出了切实可行的建议。